Journal article
Performance of 2 Finger-Stick Blood Tests to Triage Adults With Symptoms of Pulmonary Tuberculosis: A Prospective Multisite Diagnostic Accuracy Study
- Abstract:
- Background: Non–sputum-based, point-of-care triage tests for pulmonary tuberculosis could enhance tuberculosis diagnostic programs. We assessed the diagnostic accuracy of 2 finger-stick blood tests: the Cepheid 3 gene host-response cartridge (Xpert-HR), which measures 3 host messenger RNA transcripts, and the 3-host protein multibiomarker test (MBT). Methods: We performed a prospective diagnostic accuracy study of consecutive participants with symptoms compatible with pulmonary tuberculosis in The Gambia, South Africa, Uganda, and Vietnam. A composite reference standard for active pulmonary tuberculosis incorporated chest radiography, symptom resolution, and sputum microbiological test results. A training-test set approach was used to evaluate test cutoff specificities at 90% sensitivity. Results: Between 1 November 2020 and 1 May 2023, we screened 1262 participants aged 12–70 years with cough lasting >2 weeks and another symptom suggestive of tuberculosis. Of those who were classifiable by reference tests, 1154 participants had evaluable Xpert-HR results and 961 had evaluable MBT results. Xpert-HR had an area under the receiver operating characteristic (AUROC) curve of 0.92 at a cutoff of −1.275 or below, with a sensitivity of 92.8%, specificity of 62.5%, positive predictive value of 47.9%, and negative predictive value of 95.9%. The MBT had an AUROC of 0.91 at a cutoff of ≥0.42, with a sensitivity of 91.4%, specificity of 73.2%, positive predictive value of 52.0%, and negative predictive value of 96.4%. Conclusions: Our results show that both Xpert-HR and the MBT are promising non–sputum-based point-of-care tests. The MBT met the World Health Organization target product profile for a triage test, which suggests it should be further developed.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 810.5KB, Terms of use)
-
(Preview, Other, pdf, 1.0MB, Terms of use)
-
- Publisher copy:
- 10.1093/cid/ciaf105
Authors
+ European & Developing Countries Clinical Trials Partnership
More from this funder
- Funder identifier:
- https://ror.org/031jv9v19
- Publisher:
- Oxford University Press
- Journal:
- Clinical Infectious Diseases More from this journal
- Volume:
- 81
- Issue:
- 4
- Pages:
- 857-866
- Publication date:
- 2025-04-16
- DOI:
- EISSN:
-
1537-6591
- ISSN:
-
1058-4838
- Language:
-
English
- Keywords:
- Pubs id:
-
2119775
- UUID:
-
uuid_7a672a32-298d-4a9f-8ce8-228e5934ec55
- Local pid:
-
pubs:2119775
- Source identifiers:
-
3455084
- Deposit date:
-
2025-11-09
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2025
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record